Descrizione del progetto
Colmare le lacune per un’innovazione sanitaria all’avanguardia
La corsa dell’Europa per rimanere competitiva sulla scena mondiale riceverà un impulso con l’avvio del progetto NOBEL, finanziato dall’UE. Riconoscendo la necessità di nanomedicinali innovativi e tecnologie mediche all’avanguardia, questa iniziativa ambiziosa intende rivoluzionare il settore. Sfruttando la potenza delle nanotecnologie, della fotonica, della robotica, dei materiali avanzati e delle tecnologie informatiche, NOBEL creerà un ecosistema senza soluzione di continuità che collegherà tutte le parti interessate ed eliminerà gli ostacoli lungo la catena del valore. In particolare, il progetto si propone di accelerare lo sviluppo e l’industrializzazione di PMI innovative nel campo della nanomedicina e delle tecnologie mediche. Il risultato atteso è una rinascita dell’economia europea, che genererà posti di lavoro preziosi e aprirà la strada a un futuro più luminoso.
Obiettivo
In order to compete globally, Europe has to innovate and develop nanomedicines and medical technologies with high value and high technological content, well protected IP, and ensuring both a clinical need and commercial opportunities of all new innovations. Technically, this will be achieved by combining elements of key enabling technologies like nanotechnologies, photonics, robotics, advanced materials and information technologies to get smart medical devices and smart nanomedicines. However, the translation of the preclinical proof of concepts to the market via clinical validation, regulatory approval, and approval for reimbursement by the healthcare systems, requires a more integrated and streamlined ecosystem with less barriers between stakeholders and steps. Following their successful experience in the past 12 years of development in nanomedicine and medical technologies, ETPN and the seven other partners of NOBEL are merging their networks to set up a coherent, robust and unique ecosystem where information flow will improve awareness all along the value chain right up to the market access. It develops interactions, cooperation and implementation of complementary actions at local, regional, national, European and even international levels. The building of this ecosystem is based on two main pillars: a joint vision of the strategy for the future (roadmapping) and a high cohesion and interrelationship among the members of the ecosystem. One of the most significant and impactful outputs of this inclusive efficient ecosystem is the tangible acceleration of the development and industrialization of innovative SMEs in nanomedicine and medical technologies. This will impact the renaissance of EU economy by creating jobs and value in Europe. NOBEL will be unique in building the most efficient network of connections and synergies all along the value chain of Nanomedicine and healthcare technologies in Europe.
Campo scientifico
Parole chiave
Programma(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-NMBP-CSA-2017
Meccanismo di finanziamento
CSA - Coordination and support actionCoordinatore
75005 Paris
Francia